IONIS PHARMACEUTICALS, INC. (IONS) DISCUSSES FDA APPROVAL OF TRYNGOLZA FOR SEVERE HYPERTRIGLYCERIDEMIA AND ACUTE PANCREATITIS RISK REDUCTION TRANSCRIPT — via SEEKINGALPHA

FDA approval catalyst for severe hypertriglyceridemia and pancreatitis risk reduction.